BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/6/2025 8:31:59 AM | Browse: 10 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Application of multimodal fusion technology in early recurrence prediction and pathological analysis of hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-Hong Huang, Yi-Jing Fang, Xiao-Jun Zheng, Ce Huang, Chang-Lu Li, Bin Yu, Meng-Jie Huang, Shi-Ji Qin, De-You Huang and De-Wei Lu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the "Summit Plan (New Departure)" Project for the Development of Doctoral Degree Authorization Points and Professional Disciplines at The Affiliated Hospital of Youjiang Medical University for Nationalities |
DF20244433 |
| Self-funded Research Projects by The Guangxi Health and Wellness Committee |
Z-L20240824 |
| The Project to Enhance the Research Foundations of Young and Mid-career Faculty in Guangxi Universities |
2024KY0562 |
|
| Corresponding Author |
De-Wei Lu, Associate Chief Physician, Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, Department of Radiology, Affiliated Hospital of Youjiang Medical University for Nationalities, No. 18 Zhongshan Second Road, Baise 533000, Guangxi Zhuang Autonomous Region, China. 45934710@qq.com |
| Key Words |
Hepatocellular carcinoma; Habitat imaging; Radiomics; Early recurrence; Fusion model |
| Core Tip |
This study explores an interpretable fusion model that combines clinical, radiomics, and habitat features based on enhanced arterial-phase computed tomography images of the liver to predict early recurrence after hepatocellular carcinoma (HCC) surgery. The model outperforms traditional radiomics, clinical, and habitat models. It can help clinicians identify early recurrence of HCC after surgery. |
| Citation |
Huang LH, Fang YJ, Zheng XJ, Huang C, Li CL, Yu B, Huang MJ, Qin SJ, Huang DY, Lu DW. Application of multimodal fusion technology in early recurrence prediction and pathological analysis of hepatocellular carcinoma. World J Gastrointest Oncol 2025; In press |
 |
Received |
|
2025-09-10 08:12 |
 |
Peer-Review Started |
|
2025-09-10 08:12 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-09-23 11:41 |
 |
Revised |
|
2025-10-02 04:01 |
 |
Second Decision |
|
2025-11-06 02:48 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-11-06 08:31 |
 |
Articles in Press |
|
2025-11-06 08:31 |
 |
Publication Fee Transferred |
|
2025-10-09 04:03 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345